Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:269-274
Published online before print December 26, 2002, doi: 10.1161/01.ATV.0000054199.78458.4B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/2/269    most recent
01.ATV.0000054199.78458.4Bv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hara, M.
Right arrow Articles by Tsukamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hara, M.
Right arrow Articles by Tsukamoto, K.
Related Collections
Right arrow Acute coronary syndromes
Right arrow CV surgery: other
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:269.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans

Masumi Hara; Teruhiko Matsushima; Hiroaki Satoh; Naoyuki Iso-o; Hiroshi Noto; Masako Togo; Satoshi Kimura; Yoshiaki Hashimoto; Kazuhisa Tsukamoto

From the Department of Metabolic Diseases (M.H., H.S., N.I., H.N., M.T., S.K., K.T.) and the Department of Clinical Laboratory Medicine (Y.H.), Graduate School of Medicine, University of Tokyo, Tokyo, and the Department of Internal Medicine (T.M.), Tsukuba Memorial Hospital, Ibaraki, Japan.

Correspondence to Kazuhisa Tsukamoto, MD, Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655 Japan. E-mail kazuhisa-tky{at}umin.ac.jp

Objective— Apolipoprotein E (apoE) mediates cellular cholesterol efflux and plays a crucial role in the inhibition of atherogenesis. We investigated whether there is an isoform-specific difference in its function for cholesterol efflux from cholesterol-loaded RAW264.7 cells, a murine macrophage cell line that lacks endogenous apoE expression.

Methods and Results— When human apoE was expressed in RAW264.7 cells, apoE2 reduced cellular total cholesterol (TC) and esterified cholesterol (EC) levels significantly, whereas apoE3 and apoE4 had no effect. However, treatment of cells with 4-methylumbelliferyl-7-ß-D-xyloside (ß-DX) resulted in all 3 isoforms’ reducing cellular TC and EC contents significantly. We also investigated the effect of exogenously derived apoE on cholesterol efflux by utilizing the medium harvested from HeLa cells expressing apoE. ApoE2 and E3 reduced both cellular TC and EC contents significantly, whereas apoE4 did not. However, treatment of the cells with ß-DX resulted in all 3 exogenously derived apoE isoforms’ reducing TC and EC contents significantly. The binding ability of apoE to heparan sulfate proteoglycans examined by heparinase I treatment revealed less binding ability of apoE2 compared with that of apoE3 or apoE4.

Conclusions— The present study clarified the differential cellular cholesterol-modulating effect of apoE isoforms in macrophages, which would be due to the difference in their binding to proteoglycans.


Key Words: apolipoprotein E • isoforms • cholesterol efflux • RAW264.7 cells • heparan-sulfate proteoglycans




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. A. Pendse, J. M. Arbones-Mainar, L. A. Johnson, M. K. Altenburg, and N. Maeda
Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond
J. Lipid Res., April 1, 2009; 50(Supplement): S178 - S182.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. R. Riddell, H. Zhou, K. Atchison, H. K. Warwick, P. J. Atkinson, J. Jefferson, L. Xu, S. Aschmies, Y. Kirksey, Y. Hu, et al.
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
J. Neurosci., November 5, 2008; 28(45): 11445 - 11453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Altenburg, L. Johnson, J. Wilder, and N. Maeda
Apolipoprotein E4 in Macrophages Enhances Atherogenesis in a Low Density Lipoprotein Receptor-dependent Manner
J. Biol. Chem., March 16, 2007; 282(11): 7817 - 7824.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Bartzokis, P. H. Lu, D. H. Geschwind, N. Edwards, J. Mintz, and J. L. Cummings
Apolipoprotein E Genotype and Age-Related Myelin Breakdown in Healthy Individuals: Implications for Cognitive Decline and Dementia
Arch Gen Psychiatry, January 1, 2006; 63(1): 63 - 72.
[Abstract] [Full Text] [PDF]